Harbour Investments’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-656
Closed -$28.6K 3010
2022
Q4
$28.6K Sell
656
-218
-25% -$9.26K ﹤0.01% 1528
2022
Q3
$37K Hold
874
﹤0.01% 1378
2022
Q2
$37K Buy
+874
New +$38K ﹤0.01% 1378
2021
Q4
$42K Buy
867
+3
+0.3% +$142 ﹤0.01% 1330
2021
Q3
$41K Buy
864
+3
+0.3% +$146 ﹤0.01% 1884
2021
Q2
$42K Buy
861
+2
+0.2% +$96 ﹤0.01% 1916
2021
Q1
$40K Buy
+859
New +$40.7K ﹤0.01% 1820

Other funds holding BME

Harbour Investments's BME Position: Q1 2023 in Review

Harbour Investments sold out of BlackRock Health Sciences Trust (BME) in Q1 2023, closing a stake of 656 shares — an estimated $28.6K sold.

Harbour Investments first reported a position in BME in Q1 2021 and held it in 7 quarters. The position peaked at $42K in Q4 2021. 71 funds tracked by Wall St. Rank hold BME as of Q1 2023.

  • Harbour Investments reported no remaining BlackRock Health Sciences Trust position as of Q1 2023 after selling out during the quarter.
  • Harbour Investments sold 656 BlackRock Health Sciences Trust shares in Q1 2023, an estimated $28.6K.
  • Harbour Investments first reported a position in BlackRock Health Sciences Trust in Q1 2021 and held it in 7 quarters.
  • Harbour Investments's BlackRock Health Sciences Trust position peaked at $42K in Q4 2021.
  • 71 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2023.

Based on Harbour Investments's 13F filing for Q1 2023, filed 15 May 2023.